Cowealth Ebitda from 2010 to 2025

603122 Stock   7.23  0.14  1.90%   
Cowealth Medical's EBITDA is increasing over the years with slightly volatile fluctuation. EBITDA is expected to dwindle to about 136 M. From 2010 to 2025 Cowealth Medical EBITDA quarterly data regression line had arithmetic mean of  122,944,929 and r-squared of  0.58. View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
149.3 M
Current Value
136 M
Quarterly Volatility
9.3 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cowealth Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cowealth Medical's main balance sheet or income statement drivers, such as Tax Provision of 18.9 M, Net Interest Income of 603.7 K or Interest Income of 6.5 M, as well as many indicators such as . Cowealth financial statements analysis is a perfect complement when working with Cowealth Medical Valuation or Volatility modules.
  
This module can also supplement various Cowealth Medical Technical models . Check out the analysis of Cowealth Medical Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Cowealth Stock

Cowealth Medical financial ratios help investors to determine whether Cowealth Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cowealth with respect to the benefits of owning Cowealth Medical security.